Kimberly-Clark Corporation (KMB)
Automate Your Wheel Strategy on KMB
With Tiblio's Option Bot, you can configure your own wheel strategy including KMB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KMB
- Rev/Share 51.6842
- Book/Share 5.2777
- PB 21.3061
- Debt/Equity 3.9718
- CurrentRatio 0.7453
- ROIC 0.1762
- MktCap 34603176274.0
- FreeCF/Share 8.3368
- PFCF 12.4606
- PE 17.1841
- Debt/Assets 0.3758
- DivYield 0.0483
- ROE 1.5156
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | KMB | Argus | Hold | Buy | -- | $120 | Nov. 13, 2025 |
| Downgrade | KMB | Evercore ISI | Outperform | In-line | -- | $120 | Nov. 4, 2025 |
| Upgrade | KMB | JP Morgan | Underweight | Neutral | -- | $138 | Aug. 4, 2025 |
| Resumed | KMB | Piper Sandler | -- | Overweight | -- | $144 | July 18, 2025 |
| Downgrade | KMB | TD Cowen | Buy | Hold | -- | $145 | Jan. 8, 2025 |
News
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger
Published: November 03, 2025 by: The Street
Sentiment: Positive
The deal would bring Huggies, Kleenex, Band-Aid, Neutrogena, and Tylenol under one roof, creating a consumer staples giant. Transcript: Caroline Woods: Big brands and big money - Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock deal.
Read More
Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know
Published: November 03, 2025 by: Investopedia
Sentiment: Positive
Kenvue (KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark (KMB) said it's buying the Tylenol maker in a $48.7 billion deal.
Read More
Kimberly-Clark to acquire Tylenol-maker Kenvue in $48.7B deal
Published: November 03, 2025 by: Proactive Investors
Sentiment: Positive
Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in a cash and stock transaction valued at approximately $48.7 billion. Under the agreement, Kenvue shareholders will receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share, totaling $21.01 per share based on Kimberly-Clark's recent stock price.
Read More
Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal
Published: November 03, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
Kimberly-Clark agreed to buy Kenvue in a deal worth roughly $40 billion in a combination that could create a company with $32 billion in revenue and allow it to surpass Unilever to become the second-biggest seller of health and wellness products after Procter & Gamble. Eric Pfanner reports on Bloomberg Television.
Read More
Tylenol Maker Eyes Best Day Ever on Kimberly-Clark Deal
Published: November 03, 2025 by: Schaeffers Research
Sentiment: Positive
Tylenol maker and former Johnson & Johnson (JNJ) spinoff Kenvue Inc (NYSE:KVUE) is 16.7% higher to trade at $16.74, after Kimberly-Clark Corp (NASDAQ:KMB) agreed to purchase the pharma name for $48.70 billion in cash and stock.
Read More
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Published: November 03, 2025 by: New York Post
Sentiment: Positive
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Read More
Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.
Published: November 03, 2025 by: WSJ
Sentiment: Neutral
D.E. Shaw, one of the Tylenol-maker's largest shareholders, stood to lose over $200 million but is now expected to break even on its bet.
Read More
Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal
Published: November 03, 2025 by: Forbes
Sentiment: Neutral
This is a developing story.
Read More
KMB Q3 Earnings Beat Estimates, Sales In Line With the Year-Ago Level
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB's Q3 results highlight steady sales, solid volume gains and cost discipline amid ongoing margin pressures.
Read More
Kimberly-Clark (KMB) Reports Q3 Earnings: What Key Metrics Have to Say
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Kimberly-Clark (KMB) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Kimberly-Clark Corporation (KMB) Q3 2025 Earnings Call Transcript
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation ( KMB ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Christopher Jakubik - Investor Relations Contact Michael Hsu - Chairman & CEO Russell Torres - President & COO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Javier Escalante Manzo - Evercore ISI Institutional Equities, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Peter Grom - UBS Investment Bank, Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Nik Modi - RBC Capital Markets, Research Division Anna Lizzul - BofA Securities, Research Division Presentation Operator Good day, everyone, …
Read More
KMB to Report Q3 Earnings: Should You Expect a Beat This Time?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB faces currency and cost pressures ahead of Q3 results, but its Powering Care strategy may offer some relief.
Read More
3 Dividend Stocks to Double Up on Right Now
Published: October 26, 2025 by: The Motley Fool
Sentiment: Positive
Verizon shares have slipped since a new CEO was announced, pumping up its already juicy dividend yield. Realty Income is a REIT that takes great pride in its status as “The Monthly Dividend Company.
Read More
5 Best Dividend Stocks in the Nasdaq Composite
Published: October 20, 2025 by: 24/7 Wall Street
Sentiment: Positive
What's the first thing that springs to mind when someone mentions the Nasdaq Composite?
Read More
100 Barron's Sustainable Dividend Dogs: 4 Ideal October Buys; 9 To Watch; 49 "Safer"
Published: October 15, 2025 by: Seeking Alpha
Sentiment: Positive
Barron's 2025 list of 100 top sustainable companies, ranked by Calvert's ESG criteria, highlights 82 dividend payers ideal for yield-based analysis. Top-ten October 2025 Sustainable dividend-dogs, Regions Financial, Hormel, Air Products, PPG, Interpublic, Keurig Dr. Pepper, Stanley Black & Decker, Robert Half, Avient, and LKQ, ranged 24.25% 49.98% in one-year net-gains. $5k invested in the lowest-priced five of ten top-yield Sustainable companies showed 12.38% more net gain than from $5k invested in all ten per October 10 data.
Read More
Will KMB's Powering Care Strategy & Other Efforts Drive Growth?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly-Clark powers growth through innovation, premiumization and its transformative Powering Care strategy.
Read More
Kimberly-Clark Launches Enhanced Global Partnerships to Advance Essential Care for 24 Million Women and Girls
Published: October 09, 2025 by: PRNewsWire
Sentiment: Neutral
DALLAS , Oct. 9, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) is deepening its commitment to advancing essential care for women and girls through four enhanced strategic, charitable partnerships. Through new programs with Baby2Baby, Plan International, Project HOPE, and UNICEF, Kimberly-Clark aims to expand access to life-changing care in Brazil, Peru, China, India, Indonesia, Vietnam, and the United States.
Read More
Trade Tracker: Jenny Harrington buys Millrose Properties and Kimberly-Clark
Published: October 07, 2025 by: CNBC Television
Sentiment: Positive
Jenny Harrington, CEO at Gilman Hill Asset Management, joins CNBC's "Halftime Report" to detail her latest buys.
Read More
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
Kimberly-Clark Leverages Innovation and Premiumization to Aid Growth
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB drives growth through innovation, premiumization and its Powering Care strategy focused on efficiency and consumer engagement.
Read More
Kimberly-Clark Corporation (KMB) Presents At Piper Sandler's Growth Frontiers Conference (Transcript)
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (NASDAQ:KMB ) Piper Sandler's Growth Frontiers Conference September 10, 2025 10:30 AM EDT Company Participants Michael Hsu - Chairman & CEO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Michael Lavery - Piper Sandler & Co., Research Division Presentation Michael Lavery Managing Director & Senior Research Analyst All right. Well, thanks, everyone, for coming.
Read More
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Kimberly-Clark Corporation (KMB) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Published: September 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (NASDAQ:KMB ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 8:15 AM EDT Company Participants Russell Torres - President & COO Michael Hsu - Chairman & CEO Nelson Urdaneta - Senior VP & CFO Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
Read More
Kimberly-Clark: Portfolio Realignment Supports Upside Case
Published: August 07, 2025 by: Seeking Alpha
Sentiment: Positive
Kimberly-Clark is emerging from a challenging period with improving revenue, rising margins, and a 4% dividend yield, yet remains undervalued by the market. Strategic restructuring, including divesting low-margin businesses and focusing on core personal care, is driving higher quality growth and operational efficiency. Valuation metrics and DCF analysis indicate a 9-14% upside, supporting my Buy rating with a $142 target price and confidence in earnings recovery.
Read More
Kimberly-Clark Appoints John Carmichael as President, North America
Published: August 07, 2025 by: PRNewsWire
Sentiment: Neutral
DALLAS , Aug. 7, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of John Carmichael as President, North America, effective September 15th. Carmichael succeeds interim President Kurt Laufer, who will resume his prior role as President of U.S. Consumer Sales.
Read More
Kimberly-Clark Corporation (KMB) Q2 2025 Q&A Call Transcript
Published: August 01, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (NASDAQ:KMB ) Q2 2025 Q&A Conference Call August 1, 2025 8:00 AM ET Company Participants Christopher M. Jakubik - Corporate Participant Investor Relations Contact - Corporate Participant Michael D.
Read More
Kimberly-Clark's Q2 Earnings Top Estimates, 2025 Outlook Raised
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB beats second-quarter estimates despite sales dip, driven by five-year high volume growth, and raises 2025 outlook.
Read More
Kimberly-Clark (KMB) Reports Q2 Earnings: What Key Metrics Have to Say
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Kimberly-Clark (KMB) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Kimberly-Clark (KMB) Expected to Beat Earnings Estimates: Should You Buy?
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
GO vs. KMB: Which Stock Should Value Investors Buy Now?
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Kimberly-Clark (KMB). But which of these two stocks is more attractive to value investors?
Read More
About Kimberly-Clark Corporation (KMB)
- IPO Date 1980-03-17
- Website https://www.kimberly-clark.com
- Industry Household & Personal Products
- CEO Michael D. Hsu
- Employees 38000